United States · Platforms & data · MarketBeat

BioNTech (NASDAQ:BNTX) Stock Price Target Lowered at Wells Fargo & Company

Published by MarketBeat · United States 1 h ago

Wells Fargo & Company decreased their price objective on BioNTech from $140.00 to $125.00 and set an "overweight" rating for the company in a report on Wednesday.

Read the full article on MarketBeat Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.marketbeat.com)

Also worth reading

Seeking Alpha

Moderna says Ebola vaccine picked for Phase 2/3 trial in Africa

The Motley Fool

Why Palantir Technologies Stock Dropped Today

MarketWatch

Medicare prescription drug costs will jump 50% in 2027. Doing nothing could cost you.

CNBC

10-year Treasury yield is little changed as traders mull over Democrats' midterm victories

Benzinga

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

TheStreet